OCT 29, 2019 8:00 AM PDT

Multi-omics Approach to Understanding PD-L1 Resistance in Cancer

Sponsored by: Sony Biotechnology
C.E. Credits: P.A.C.E. CE Florida CE
Speakers

Abstract

DATE: October 29, 2019

TIME:  8:00am PDT

Although immune-based therapies targeting the inhibitory receptors (PD-L1, PD1, and CTLA4) are proven to be effective to treat cancer, some patients do not respond, or stop responding within the first year of therapy. Identifying the underlying mechanisms associated with these variable response rates remains an important open research challenge in clinical oncology.

Join this free webinar to learn how researchers are integrating cell sorting, RNA sequencing, ex-vivo phenotype profiling, and patient-derived xenografts to study the mechanisms of PD-L1 resistance in cancer.

 

Who Should Attend:

Researchers who want to integrate a multi-omics approach in their clinical studies on immune checkpoint inhibitor resistance will gain valuable insights. In addition, the webinar will benefit those who want to learn about new technologies for isolating and profiling tumor cells. 

 

Learning Objectives:

  • Review how a multi-omics approach can be used to study the resistance mechanisms to therapies targeting immune checkpoint inhibitors.

  • Evaluate how new clinical research tools can uncover complexities of tumors and their ecosystems.  

 

Webinars will be available for unlimited on-demand viewing after live event.

 

LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.


Show Resources
You May Also Like
MAY 11, 2021 10:00 AM PDT
C.E. CREDITS
MAY 11, 2021 10:00 AM PDT
Date: May 11, 2021 Time: 10:00zm PDT Your samples are some of the most valuable assets in the laboratory. After spending countless hours on extraction and preparation, your conclusions could...
JUN 09, 2021 7:00 AM PDT
C.E. CREDITS
JUN 09, 2021 7:00 AM PDT
Date: June 9, 2021 Time: 09 June 2021, 7am PDT, 10am EDT, 4pm CEST cells with dramatic implications on the validity of past cell culture related research. The fact that at least 509 cell lin...
APR 21, 2021 5:00 PM CEST
APR 21, 2021 5:00 PM CEST
Date: April 21, 2021 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Spatial Answers Trilogy - Spatial Answers in Immunology Immunology Researchers share their Spatial Discoveries in SARS-C...
MAR 18, 2021 8:00 AM PDT
C.E. CREDITS
MAR 18, 2021 8:00 AM PDT
DATE: March 18, 2021 TIME: 8:00am PDT Sequencing of bulk cells, single cells, and nuclei is opening doors in the understanding of complex biological processes....
JUL 15, 2021 9:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
JUL 15, 2021 9:00 AM PDT
Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
Date: July 15, 2021 Time: 9:00am (PDT), 12:00pm (EDT) The Pisces workflow robust, easy-to-use, end-to-end multi-omics solution for highly multiplexed targeted Spatial RNA analysis. VeranomeB...
MAR 16, 2021 10:00 AM PDT
C.E. CREDITS
MAR 16, 2021 10:00 AM PDT
Date: March 16, 2021 Time: 10:00am (PST) Scientific progress and breakthroughs today are often too expensive for most institutions to acquire. Each year, the National Institutes of Health (N...
OCT 29, 2019 8:00 AM PDT

Multi-omics Approach to Understanding PD-L1 Resistance in Cancer

Sponsored by: Sony Biotechnology
C.E. Credits: P.A.C.E. CE Florida CE

Specialty

Cancer Research

Molecular Biology

Immunology

Cell Biology

Biomarkers

Cancer Diagnostics

Cancer Therapeutics

Biotechnology

Molecular Diagnostics

Oncology

Genomics

Genetics

Clinical Research

Gene Expression

Cell Culture

Geography

North America57%

Europe19%

Asia15%

South America4%

Africa3%

Oceania1%

Registration Source

Email Promotions45%

Website Visitors34%

WAVE Newsletter Promotion10%

Trending Newsletter Promotion5%

Other6%

Job Title

Scientist13%

Executive13%

Research Scientist13%

Student11%

Educator/Faculty11%

Facility/Department Manager7%

Medical Laboratory Technician7%

Medical Doctor/Specialist6%

Post Doc5%

Lab Management5%

Clinical Laboratory Scientist4%

Pathologist2%

Consultant1%

Engineer1%

Chemist1%

Organization

Academic Institution27%

Biotech Company12%

Hospital9%

Clinical Laboratory8%

Pharmaceutical Company7%

Research Institute6%

Life Science Company4%

Medical Center3%

Medical School3%

Government2%

Non-Profit Organization2%

Consultant2%

Contract Research Organization (Cro)1%

Manufacturer & Biotech/pharma1%

Other2%


Show Resources
Loading Comments...
Show Resources
Attendees
  • See more